Hemoglobin News and Research

RSS

Joint associations of genetic risk and diet quality with incident type 2 diabetes

Researchers assessed the impact of polygenic scores and diet quality on type 2 diabetes.

3 May 2022

Uncovering a new molecule that shows potential as antidote for carbon monoxide poisoning

Carbon monoxide is an odorless and colorless gas made when fossil fuels burn incompletely. It's also a silent killer.

29 Apr 2022

Study explores sex-driven differences in individualized clinical management of Alzheimer’s disease risk

A new study demonstrated how individualized clinical management of Alzheimer's disease risk was viable in a clinical outpatient setting.

29 Apr 2022

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

Researchers at Ural Federal University have proposed the use of polyoxometallate nanoclusters as a carrier for chemotherapy drug. It will help to deliver medications precisely to the focus of a pathological process, such as a cancerous tumor, without toxic effects on healthy cells.

28 Apr 2022

The brain's reaction to COVID's inflammatory tidal wave

Researchers study neuroinflammation in the cerebrospinal fluid and serum of patients infected with SARS-CoV-2.

18 Apr 2022

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Researchers reviewed non-viral nano-vectors used for delivering the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated genome editing system.

14 Apr 2022

UNSW research improves fundamental understanding of the mechanism behind sickle cell disease

UNSW researchers have used CRISPR gene editing – a type of 'molecular scissors' – to understand how deletions in one area of the genome can affect the expression of nearby genes.

8 Apr 2022

New ML models show high accuracy in predicting complications after abdominal hernia repair

Machine learning (ML) models developed by surgeons at the University of Texas MD Anderson Cancer Center in Houston have shown a high level of accuracy in predicting which types of patients are most likely to have a hernia recurrence or other complications.

7 Apr 2022

EMA issues qualification opinion for islet autoantibodies as enrichment biomarkers for T1D prevention trials

Critical Path Institute's Type 1 Diabetes Consortium (T1DC) today announced that the European Medicines Agency has issued a positive qualification opinion for pancreatic islet autoantibodies as enrichment biomarkers for type 1 diabetes (T1D) prevention trials.

5 Apr 2022

Study identifies new risk factors for recovery after reconstructive breast surgery

Factors such as anemia and anticoagulants have more impact on hospitalization time after breast reconstruction than "common" risk factors.

4 Apr 2022

CDK6: a potential drug target for severe COVID-19

Researchers identify a methodology and workflow to repurpose drugs against the cyclin-dependent kinase 6 target gene of SARS-CoV-2.

27 Mar 2022

Study investigates incident diabetes burden and risk in post-acute COVID-19 patients

Researchers examined the post-acute risk and burden of incident diabetes beyond the initial 30 days of COVID-19.

25 Mar 2022

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Researchers assessed the prevalence of organ impairment in long COVID six months and a year post-COVID-19 at London and Oxford.

24 Mar 2022

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Researchers performed an in situ analysis to evaluate the correlation between CD48 expression and COVID-19.

22 Mar 2022

Evidence of COVID-19 impacts on glycated hemoglobin levels in a real-world clinical cohort

Researchers established the impact of SARS-CoV-2 infection on glycated hemoglobin levels, type 2 diabetes risk, and diabetic ketoacidosis through data from the large real-world clinical cohort.

17 Mar 2022

Tumor cells’ 'ferroaddiction' can be exploited to deliver powerful anticancer drugs

Researchers at the University of California, San Francisco, have discovered that cells carrying the most common mutation found in human cancer accumulate large amounts of ferrous iron and that this "ferroaddiction" can be exploited to specifically deliver powerful anticancer drugs without harming normal, healthy cells.

11 Mar 2022

Hemoglobin News and Research

Joint associations of genetic risk and diet quality with incident type 2 diabetes

Uncovering a new molecule that shows potential as antidote for carbon monoxide poisoning

Study explores sex-driven differences in individualized clinical management of Alzheimer’s disease risk

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

The brain's reaction to COVID's inflammatory tidal wave

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

UNSW research improves fundamental understanding of the mechanism behind sickle cell disease

New ML models show high accuracy in predicting complications after abdominal hernia repair

EMA issues qualification opinion for islet autoantibodies as enrichment biomarkers for T1D prevention trials

Study identifies new risk factors for recovery after reconstructive breast surgery

CDK6: a potential drug target for severe COVID-19

Study investigates incident diabetes burden and risk in post-acute COVID-19 patients

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Evidence of COVID-19 impacts on glycated hemoglobin levels in a real-world clinical cohort

Tumor cells’ 'ferroaddiction' can be exploited to deliver powerful anticancer drugs

IPD pooled analysis quantifies the underlying hematological response following malaria infection

High prevalence of new-onset diabetes with ketoacidosis observed in children during COVID-19 pandemic

Study does not find association between hematological parameters and COVID-19-related hospitalization

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News